MedTrace Logo

One, Two, or Three iStents for the Reduction of Intraocular Pressure in Open-angle Glaucoma Subjects

NCT01517477 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2022-08-31

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the intraocular pressure (IOP) lowering effect of one, two, or three iStent devices in eyes of subjects previously on two anti-glaucoma medications.

Conditions

  • Primary Open Angle Glaucoma (POAG)

Interventions

DEVICE

iStent

Implantation of One iStent through a small temporal clear corneal incision.

DEVICE

iStent

Implantation of Two iStents through a small temporal clear corneal incision

DEVICE

iStent

Implantation of Three iStents through a small temporal clear corneal incision

Sponsors & Collaborators

  • Glaukos Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2019-10-18
Completion
2019-10-18

Countries

  • Armenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01517477 on ClinicalTrials.gov